Asarina Pharma Q3’20: Operational Progress
Research Note
2020-11-25
10:39
Redeye notes that Asarina Pharma remains on track to report and initiate phase 2a studies in Q2'21. The finances came in largely as expected.
AH
Anders Hedlund
Disclosures and disclaimers